Type
. Genetic control of innate resistance to mycobacterial infections. Immunology today. 1991;12(3):A42-5.
Type
. Leprosy and cell-mediated immunity. Current opinion in immunology. 1991;3(1):91-6.
Type
. Leprosy control activities of the International Federation of Anti-leprosy Associations. World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales. 1991;44(1):36-46.
Type
. Global review of multidrug therapy (MDT) in leprosy. World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales. 1991;44(1):2-15.
Type
. Leprosy in the WHO African region. World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales. 1991;44(1):16-22.
Type
. Immunoreactivity of nerve lipid antigens in leprosy. Journal of clinical laboratory analysis. 1991;5(3):157-61.
Type
. Pathosis of the hard and soft palate. The Journal of prosthetic dentistry. 1978;39(4):436-40.
Type
. [Neuropathies of the ulcero-mutilating type. Clinical aspects, classification, circulation measurements]. VASA. Supplementum. 1977;6:1-48.
Type
. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1991;59(2):332-4. Available from: http://ila.ilsl.br/pdfs/v59n2a19.pdf
Type
. Precautionary note for observing signs of activity (or relapse) in treated leprosy patients. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1991;59(2):322-3. Available from: http://ila.ilsl.br/pdfs/v59n2a15.pdf